A siege map. A missed train. A thermostat that suddenly decides your apartment is the surface of Mercury. These sound unrelated, but they share one nasty trick: timing changes everything. That is the hidden connection in this paper too. For some people, the menstrual cycle does not just move dates around on a calendar - it can shift brain chemistry in ways that line up with spikes in suicidal thoughts and, in the worst cases, planning and attempts.[1-6]

The paper by Ross, Patterson, and Eisenlohr-Moul is a selective review. In plain English: the authors looked across the evidence and asked a sharper question. If suicide risk rises during certain parts of the menstrual cycle in some hormone-sensitive people, what brain systems are carrying the message from the ovaries to the rest of the operation?[1]

The Monthly Ambush

The broad idea is simple and medicine has still managed to act weirdly evasive about it. Estradiol, progesterone, and a progesterone-derived neurosteroid called allopregnanolone rise and fall across the menstrual cycle. In many people, that is just normal physiology. In a susceptible subgroup, those shifts seem to hit the brain hard. Symptoms often worsen in the late luteal and perimenstrual window, when hormone levels are changing fast.[1,3-6]

That timing pattern has shown up in more than one place. A 2024 American Journal of Psychiatry study tracking daily symptoms in psychiatric outpatients with suicidality found cyclical changes in suicidal ideation and planning, with depression, hopelessness, rejection sensitivity, and perceived burdensomeness helping explain the swing.[3] Another clinical trial found that giving estradiol and progesterone around the perimenstrual phase reduced worsening of suicidal ideation and related symptoms.[5]

Six Suspects, No Single Mastermind

The review lays out six "candidate systems." Translation: six biochemical crews that might help explain why the cycle can become a danger window.

First, serotonin. It helps regulate mood, impulse control, and aggression. Estradiol can influence serotonin synthesis and signaling, so hormone changes may alter the tone of that whole network.[1]

Second, GABA and allopregnanolone. If serotonin is the diplomat, GABA is the brain's brake pedal. Allopregnanolone, made from progesterone, usually boosts GABA-A receptor activity and helps calm neural firing. But some hormone-sensitive brains seem to react paradoxically to changes in allopregnanolone.[1,4]

Third, dopamine. Reward, motivation, and impulsive action all run through dopaminergic circuits. Estradiol can tune dopamine signaling, which matters when suicidal crises involve not just misery, but also shifts in drive, decision-making, and risky behavior.[1]

Then come the less famous but very real players: neurotrophic systems such as BDNF, which support plasticity and stress adaptation; lipid and inflammatory pathways, which influence cell membranes and signaling; and DHEA(S), another steroid system tied to stress biology and affect regulation.[1] The point is that suicide risk may emerge when several systems wobble at once.

Why This Hits Hard

What makes this review matter is not just the biology. It is the tactical implication. Suicide prevention usually treats risk as either chronic or mysterious. But if some people have a recurring, partly predictable danger period each month, that opens the door to precision prevention: closer monitoring during high-risk days, individualized symptom tracking, hormone-informed treatment trials, and maybe eventually interventions timed to the exact phase when the trapdoor tends to open.[1,3,6]

That idea is gaining traction. A 2024 perspective argued that menstrual cycle data could be folded into just-in-time adaptive interventions for suicide prevention.[6] Recent clinical commentary has made a similar point: the cycle is not background noise. For some patients, it is the signal.[2]

The Problem Medicine Built for Itself

There is also an older, more embarrassing subplot here. Women's health research has a long history of treating cyclical biology like an inconvenience to be controlled away, not a source of insight. So yes, part of the drama here is self-inflicted. We ignored the timetable, then acted surprised when timing mattered.

To be clear, this review does not say the menstrual cycle causes suicidality in everyone, or that hormones are destiny. It says something more useful: in a vulnerable subset of people, normal ovarian hormone fluctuations may interact with brain systems already involved in mood regulation, cognitive control, and stress response. That is a testable model.

The war-room takeaway is blunt. Timing matters. Hormone sensitivity matters. And if researchers can map who is vulnerable, when risk rises, and which molecular systems go sideways first, suicide prevention could become less like guessing in the fog and more like spotting the artillery before it fires.

References

1. Ross A, Patterson AM, Eisenlohr-Moul TA. Molecular Mechanisms of Menstrual Cycle-Related Suicide Risk: A Selective Review of Promising Candidate Systems. Biological Psychiatry. 2025. DOI: https://doi.org/10.1016/j.biopsych.2025.12.005. PubMed: https://pubmed.ncbi.nlm.nih.gov/41390123/

2. Rubinow DR. Suicide and the Menstrual Cycle. American Journal of Psychiatry. 2024;181(1):11-13. DOI: https://doi.org/10.1176/appi.ajp.20230860. PubMed: https://pubmed.ncbi.nlm.nih.gov/38161294/

3. Owens SA, Pedersen CA, Peters JR, et al. Predicting Acute Changes in Suicidal Ideation and Planning: A Longitudinal Study of Symptom Mediators and the Role of the Menstrual Cycle in Female Psychiatric Outpatients With Suicidality. American Journal of Psychiatry. 2024;181(1):57-67. DOI: https://doi.org/10.1176/appi.ajp.20230303. PubMed: https://pubmed.ncbi.nlm.nih.gov/38093647/

4. Peters JR, Schmalenberger KM, Eng AG, et al. Dimensional Affective Sensitivity to Hormones across the Menstrual Cycle (DASH-MC): A transdiagnostic framework for ovarian steroid influences on psychopathology. Molecular Psychiatry. 2025;30(1):251-262. DOI: https://doi.org/10.1038/s41380-024-02693-4. PMCID: https://pmc.ncbi.nlm.nih.gov/articles/PMC12053596/

5. Eisenlohr-Moul TA, Rubinow DR, Schiller CE, et al. Effects of acute estradiol and progesterone on perimenstrual exacerbation of suicidal ideation and related symptoms: a crossover randomized controlled trial. Translational Psychiatry. 2023;13:6. DOI: https://doi.org/10.1038/s41398-022-02294-1. PMCID: https://pmc.ncbi.nlm.nih.gov/articles/PMC9803670/

6. Ross A, Eisenlohr-Moul TA. A call to integrate menstrual cycle influences into just-in-time adaptive interventions for suicide prevention. Frontiers in Psychiatry. 2024;15:1434499. DOI: https://doi.org/10.3389/fpsyt.2024.1434499. PMCID: https://pmc.ncbi.nlm.nih.gov/articles/PMC11655188/

Disclaimer: The image accompanying this article is for illustrative purposes only and does not depict actual experimental results, data, or biological mechanisms.